Previous close | 273.50 |
Open | 273.50 |
Bid | 195.10 |
Ask | 199.40 |
Strike | 710.00 |
Expiry date | 2025-01-17 |
Day's range | 273.50 - 273.50 |
Contract range | N/A |
Volume | |
Open interest | 163 |
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN), Pfizer (PFE), Sanofi (SNY) and Bayer (BAYRY) are worth retaining in one's portfolio.
As the United States stock market reaches new heights, buoyed by a robust jobs report and record highs in major indices like the Dow Jones Industrial Average, investors are keenly observing opportunities amid this positive economic sentiment. In such an environment, identifying stocks that might be trading below their fair value can offer potential for growth, especially as the Federal Reserve's monetary policy remains a focal point for market participants.
We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other momentum stocks. U.S. Labor Market Remains Resilient After the Fed’s rate cut and a positive inflation report, the latest […]